Aptamer Group making headlines on their Point of Care COVID-19 reagent developments

Arron Tolley, CEO of Aptamer Group discusses the teams progress on COVID-19 tests: 17/06/2020 Scientists at York-based biotechnology company Aptamer Group are using their expertise to develop a COVID-19…

Optimizing your PCR to avoid non-specific amplification – Aptamer mediated Hot start PCR to detect MERS-CoV

Polymerase chain reaction (PCR) is an established method to amplify specific fragments of DNA, for applications such as gene cloning, genetic fingerprinting and diagnosis of disease. Although PCR reactions…